Eagle Pharmaceuticals Commences $25 Million Accelerated Share Repurchase as Part of Existing $160 Million Share Repurchase ProgramBusiness Wire • 09/24/20
Eagle Pharmaceuticals’ Japanese Licensing Partner, SymBio, Receives Approval of TREAKISYM Ready-To-Dilute (“RTD”) Formulation, with Launch Expected in January 2021Business Wire • 09/23/20
Eagle Pharmaceuticals to Present at Upcoming September 2020 Healthcare ConferencesBusiness Wire • 09/08/20
Eagle Pharmaceuticals Announces Publication of Preclinical Study of Intranasal Dantrolene in Journal of Alzheimer’s DiseaseBusiness Wire • 08/19/20
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/10/20
Eagle Pharmaceuticals (EGRX) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 08/10/20
Eagle Pharmaceuticals to Discuss Second Quarter 2020 Financial Results on August 10, 2020Business Wire • 08/03/20
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)Business Wire • 07/09/20
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/11/20
Why Eagle Pharmaceuticals (EGRX) Might Surprise This Earnings SeasonZacks Investment Research • 05/08/20
Earnings Preview: Eagle Pharmaceuticals (EGRX) Q1 Earnings Expected to DeclineZacks Investment Research • 04/28/20
Covid Report: Drug Stock Pops On New Approach To Tackling CoronavirusInvestors Business Daily • 04/16/20
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/02/20
Eagle Pharmaceuticals (EGRX) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 03/02/20
Earnings Preview: Eagle Pharmaceuticals (EGRX) Q4 Earnings Expected to DeclineZacks Investment Research • 02/24/20
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/12/19
Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/09/19
Eagle Pharmaceuticals (EGRX) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/08/19
Earnings Preview: Eagle Pharmaceuticals (EGRX) Q2 Earnings Expected to DeclineZacks Investment Research • 08/01/19
Eagle Pharmaceuticals' (EGRX) CEO Scott Tarriff on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19
Eagle Pharmaceuticals (EGRX) Beats Q1 Earnings and Revenue EstimatesZacks Investment Research • 05/07/19